# Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

> **NCT03347968** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 22 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** MEDI0382
- **DRUG:** Warfarin
- **DRUG:** Esmolol

## Key facts

- **NCT ID:** NCT03347968
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2018-04-09
- **Final completion:** 2018-04-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347968, "Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03347968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*